# OnCo record furlong (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/furlong/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "furlong", "NCT03787992" ;
  schema:name "FURLONG"@en ;
  schema:description "The head-to-head trial in which furmonertinib nearly doubled the time before lung cancer grew compared with gefitinib, mirroring FLAURA with a Chinese drug."@en ;
  schema:url <https://onco.cc/trials/furlong/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03787992>, <https://doi.org/10.1016/S2213-2600(22)00168-0> ;
  onco:status "positive" ;
  onco:tag "china" ;
  onco:phase "3" ;
  schema:startDate "2019-05-30" ;
  onco:related <https://onco.cc/trials/flaura2/>, <https://onco.cc/trials/aeneas/> ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/egfr/> ;
  onco:drugs <https://onco.cc/drugs/furmonertinib/>, <https://onco.cc/drugs/gefitinib/> ;
  onco:companies <https://onco.cc/companies/allist/> ;
  onco:institutions <https://onco.cc/institutions/shanghai-chest-hospital/> ;
  onco:people <https://onco.cc/people/lu-shun/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-furlong-lancet-respir-med-2022/> .